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1. Introduction 
Rheumatoid arthritis (RA) is an autoimmune joint disease characterized by inflammation 
and destruction of the articular surfaces and bone. During joint movement, synovial tissues 
contribute to mechanical load bearing by changing their shape. These elastic synovial 
membranes are an early target of rheumatic inflammation, and together with chondrocytes, 
become a primary source of inflammatory factors (e.g., cytokines) that enter the synovial 
fluid (Dayer, 2004, Firestein, 2007). The pathophysiological steps leading to RA include 
inflammation, proliferation of synovial cells, and attachment to and invasion of adjacent 
cartilage and bone by fibroblast-like cells derived from rheumatoid synoviocytes (RA-FLSs) 
(Firestein, 1996, Pap et al., 2000, Tolboom et al., 2005, Bartok & Firestein, 2010).  
In the healthy synovium, one to three layers of synoviocytes, the macrophage-like type A 
and the more abundant fibroblast-like type B (also referred to as synovial fibroblasts), form 
the synovial lining layer separating the synovial sublining layer of loose connective tissue 
from the joint cavity (Iwanaga et al., 2000). The joint damage observed in RA is mainly 
mediated by macrophage/macrophage-like cell-derived cytokines, such as interleukin (IL)-
1, IL-6 and tumor necrosis factor (TNF)-, which induce neutral protease production by 
FLSs and articular chondrocytes (Houssiau et al., 1988, Feldmann & Maini, 1999, Dayer, 
2002). Although IL-1 and TNF- share many biological activities that are relevant in RA, 
early studies of experimental arthritis models have demonstrated that IL-1 plays a 
predominant role in cartilage destruction via inflammatory processes that include the 
activation of matrix metalloproteinases (MMPs) (Borghaei et al., 1998) and the inhibition of 
the synthesis of extracellular matrix (ECM) molecules (Mauviel et al., 1988). In particular, IL-
1 is readily detected, long after the onset of RA, at high levels in the synovial fluid of RA 
patients. IL-1 can significantly alter the expression of a variety of genes, including 
inflammatory mediators such as cytokines and  MMPs (Sun & Yokota, 2002, Suzuki et al., 
2010). In addition, IL-1 stimulates bone resorption by activating osteoclasts (Goldring, 2003). 
That said, there is little comprehensive information available on the effects of IL-1 on 
fibroblast-like synoviocytes (FLSs).  
RA-FLSs not only mediate tissue destruction, but also are considered to play a major role in 
initiating and driving RA in concert with inflammatory cells (Huber, 2006, Bartok & 
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Firestein, 2010). However, the original roles of single RA-FLS, and their relationship with 
macrophage-like type B cells in the rheumatoid synovium are poorly understood, although 
many case reports of RA patients, and many experimental reports using the synovium 
tisuues/cells from RA patients have been published. The utilization of cells such as the 
MH7A human RA-FLSs (Cell Bank, Riken Bioresource Center, Ibaraki, Japan), which are 
established cells isolated from the knee joint of an RA patient that retain the morphological 
and functional characteristics of primary synovial cells should provide guidance to clarify 
the mechanisms of onset of RA and to the development of useful treatments for RA. The 
MH7A cells are an immortalized RA-FLS line that stains positively for IL-1R, intercellular 
adhesion molecule-1 (ICAM-1), CD16, CD40, CD80, and CD95 and has been used 
extensively to investigate the molecular mechanisms underlying RA (Miyazawa et al., 1998). 
It has been shown, for example, that IL-1 enhances the production of IL-6, IL-8, and MMPs 
in MH7A cells (Shibata et al., 2005, Han et al., 2006) in a manner similar to that seen in the 
parental FLSs, although the immortalized cells grow more rapidly than the parental cells. 
These results clearly indicate the usefulness of MH7A cells for investigating the regulation 
of rheumatoid FLSs and the IL-1 signal transduction pathway to develop a future RA 
therapy. 
In what is becoming known as the “post-genomic era”, many new technologies and 
methodologies are being developed to take advantage of the recent progress in genomic 
research. Among these, gene expression profiling has become an invaluable tool in 
functional genomics. DNA microarrays, cDNA subtraction, and the serial analysis of gene 
expression have all emerged as leading transcript profiling technologies for the global 
analysis of biological systems. One of the high throughput technologies, high-density 
oligonucleotide genechip microarrays, makes it possible to simultaneously measure the 
relative abundance of numerous mRNAs within a cell. To better understand the direct IL-
1-induced changes in gene expression that might promote inflammatory responses in 
MH7A cells, in the present study we used an Affymetrix HG-8500 Focus array GeneChip to 
analyze the patterns of gene expression, and then used the Ingenuity Pathway Analysis 
(IPA) software program to investigate the signaling pathways leading to the IL-1-induced 
gene expression. In addition, we used a biotin label-based antibody array to measure the 
levels of 507 human target proteins, including cytokines, chemokines, growth factors, 
angiogenic factors, proteases, and soluble receptors, among others, in the cell culture 
supernatants. We analyzed the expression profiles of both the genes and proteins to identify 
the key molecules involved in articular rheumatism, which could be related to the induction 
of inflammation and pannus formation in the synovial tissues of RA patients. In addition, 
we propose the possibility of a new therapy using linear polarized infrared light, that 
induces the suppression of inflammation and pain for RA patients with no apparent side-
effects.  
2. Microarray analysis 
MH7A human RA-FLSs (Riken Bioresource Center, Ibaraki) were maintained in RPMI 1640 
medium supplemented with 10% fetal calf serum (FCS) and penicillin-streptomycin at 37°C 
under a 5% CO2 atmosphere. Total RNA from the MH7A cells was treated according to the 
manufacturer’s protocol, and then hybridized to a Human Genome Focus Array HG-8500 
GeneChip (Affymetrix Inc.).  
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Our aims were to identify potential mediators of RA inflammation and joint destruction 
induced by the inflammatory cytokine IL-1 and to investigate the mechanisms responsible 
for their stimulation. Of the 8,746 genes on the Focus array HG-8500 GeneChip, 4,909 from 
untreated cells and 5,073 from IL-1-treated cells were classified as marginally expressed or 
present. After the cut-offs for induction (≥2.0-fold) and suppression (≤0.5-fold) by IL-1 
were applied, 120 genes (74 upregulated and 46 downregulated genes) were identified as 
being affected by IL-1. When we then classified the IL-1-inducible gene expression in 
MH7A cells with respect to six functionalities based on BiologicalProcess words, we found 
that IL-1 conspicuously increased the expression of inflammation and 
apoptosis/proliferation-related genes, although the largest group of genes affected by IL-1 
was signaling-related (Fig. 1). 
 
 
The genes that were upregulated (n=74) or down-regulated (n=46) by IL-1 were classified into 6 
groups based on the GO-BiologicalProcess terms listed in the GeneSpring 6.2 software program.  
Fig. 1. Classification of genes whose expression in MH7A cells was affected by IL-1.  
We used IPA to gain a better understanding of how differentially expressed genes were 
integrated into specific regulatory and signaling networks. A data set containing gene 
identifiers adhering to the 2-fold (120 genes) change used in microarray experiments was 
uploaded into the IPA software application. Each gene identifier was mapped to its 
corresponding gene object and then overlaid onto a global molecular network developed 
from information contained in the Ingenuity Pathways Knowledge Base. The networks of 
these genes were then algorithmically generated based on their connectivity, after which a 
functional analysis of the networks identified the biological functions that were the most 
significant.  
2.1 IL-1-induced inflammatory signaling pathways 
We attempted to visualize the IL-1-induced genes within the canonical IPA pathway, which 
involves IL-1, IL-6, and TNF- signaling (Fig. 2A, canonical pathway name: IL-6 signaling). 
Four IL-1-inducible genes (>2.0-fold), IL-1, IL-6, IL-8, and IB, were situated within this 
atlas. As shown in Fig. 2A, activation of NF-B signaling is also important for the secretion of 
IL-8, IL-1 and IL-6. We previously used an ELISA to show that TNF- was not expressed in 
MH7A cells, regardless of whether they were exposed to IL-1 (0.1 unit/ml) (Shibata et al., 
2005). Likewise, the results we obtained using the GeneChip microarray indicated no 
expression of TNF- in MH7A cells under our experimental conditions. IL-1 did induce its 
own expression, which may be important for its accumulation during the inflammation in RA. 
Furthermore, high levels of NF-IL6 (CEBPB) expression were consistently observed.  
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A. The IL-1 and IL-6 signaling pathways as determined by IPA analysis. Grayed symbols indicate 
genes that were upregulated by IL-1; white symbols indicate genes whose expression was not 
increased by IL-1. B. A scatter plot of 8,793 genes. Genes whose expression ratio was changed by >2-
fold by IL-1 are positioned outside the lines. C. Dose-dependent effects of IL-1 on the gene 
expression. MH7A cells were examined after treatment with fresh medium containing the indicated 
concentration of IL-1, and the cells were incubated for an additional 2 hr.  
Fig. 2. The IL-1 and IL-6 signaling pathways and the results of the RT-PCR analysis  
Based on the structural analysis, the chemokine superfamily can be divided into two groups: 
the C-X-C and the C-C subfamilies (Baggiolini et al., 1994). IL-8 belongs to the first group 
and acts mainly on neutrophils (Hebert & Baker, 1993). Our microarray experiments showed 
that IL-8 transcription was the most dramatically upregulated (20.8 fold) in MH7A cells 
exposed to IL-1. It is also noteworthy that the expression of other chemokines, including 
CXCL-1 (4.1-fold), -2 (4.0-fold) and -3 (2.7-fold), three potent stimulators of neutrophil 
activation and tissue infiltration was also enhanced. Leukocyte recruitment from the 
microvasculature to sites of inflammation is a sequential process that includes rolling, 
activation, firm adhesion, and finally, transmigration through the vessel wall (King & 
Hammer, 2001). Although macrophages, neutrophils, and endothelial cells are all thought to 
be primary sources of IL-8, which is known to be elevated at inflammatory sites such as the 
synovial fluid of RA patients, fibroblast-like and macrophage-like cells of the synovial 
membrane, together with the infiltrating leucocytes, are the major source of these mediators 
in the rheumatoid synovial pannus (Rathanaswami et al., 1993). In the GeneChip microarray 
experiment, an IL-1 concentration close to the levels seen clinically was used to stimulate 
the MH7A cells. The gene expression of IL-8, Gro- (CXCL1), Gro- (CXCL2), IL-1, and IL-
6 in scatter plots is shown in Fig. 2B. According to a RT-PCR analysis, the levels of IL-8, 
CXCL1, CXCL2, IL-1, and IL-6 mRNA in MH7A cells were all found to be dose-
dependently increased by IL-1 (Fig. 2C). Therefore, IL-8 appears to play a major role in the 
initiation and maintenance of inflammatory responses. 
Within the 5’-flanking region of the human IL-8 promoter are a number of motifs with the 
potential to bind various transcription factors in a cell and stimulus-dependent manner. In 
particular, the transcription factors NF-B and NF-IL-6 are both involved in stimulus-
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induced IL-8 expression (Matsusaka et al., 1993). We would therefore anticipate that these 
transcription factors would play an important role in the increased expression of IL-8 
mRNA elicited by IL-1, but no increases in the expression for NFKB1 (NF-B), RELA 
(RelA), or CEBPB (NF-IL-6) were seen in the microarray experiment. On the other hand, in 
resting cells, NF-B is trapped in the cytoplasm through its interaction with its inhibitor, 
IkB, and a crucial step in the activation of NF-B is the stimulus-induced phosphorylation 
of IB by IB kinases (IKKs). To study the extent to which IKKs modulate IL-1 induced 
IL-8 production, MH7A cells were pretreated with Bay11-7085, an inhibitor of IB 
phosphorylation, for 1 hr before stimulation with IL-1(Shibata et al., 2009a). As shown in 
Fig. 3, Bay11-7085 completely blocked the release of IL-8 from IL-1-stimulated MH7A 
cells.  
 
 
A. The IL-1-induced signal transduction pathways leading to the production of IL-8. Gray symbols 
indicate genes that were up-regulated by IL-1. White symbols indicate genes whose expression was 
increased less than 2.0-fold by IL-1. B. The effects of Bay11-7085 on the production of IL-8. MH7A cells 
were first incubated with the IKK/ inhibitor Bay11-7085 for 1 hr, and then with IL-1 for 2 hr. The 
levels of IL-8 in medium conditioned by the cells were measured using an ELISA. [This figure is 
modified from (Shibata et al., 2009a)] 
Fig. 3. The effect of Bay11-7085 on the production of IL-8 
2.2 Arithmetic IL-8 production through the PGE2 receptor synthesis 
PGE2, a product of the cyclooxygenation of arachidonic acid, is a potent mediator of the 
immune response and inflammation, and contributes to the pathogenesis of RA (Robinson 
et al., 1975, Trebino et al., 2003). PGE2 also displays a complex regulatory function affecting 
IL-8 gene expression, which is dependent on the concentration of PGE2 and on the specific 
cell type involved. At physiological and pathological concentrations of up to 100 μM, PGE2 
is capable of upregulating endogenous IL-8 expression in human colonic epithelial cells (Yu 
& Chadee, 1998). However, there have been many reports that PGE2 has no effect on 
neutrophil-derived IL-8 induced by LPS (Wertheim et al., 1993); that it down-regulates IL-8 
in response to LPS in human alveolar macrophages and blood monocytes (Standiford et al., 
1992); and suppresses the production of chemokines, including IL-8, in human macrophages 
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(Takayama et al., 2002). Furthermore, PGE2 alone had little detectable effect on IL-8, 
although a small enhancement of the mRNA and protein levels of IL-6 has been observed in 
human synovial fibroblasts (Agro et al., 1996). In RA research, while PGE2 alone has limited 
effects on synovial cell production of IL-8, its effects are significant in the context of IL-1 
stimulation; endogenous PGE2 may alter the cytokines secreted by mesenchymally-derived 
cells. 
A variety of transcription factors, including NF-κB, NF-IL6, activator protein-1 and octamer-
1, have been shown to regulate IL-8 gene transcription (Matsusaka et al., 1993). Caristi et al 
(Caristi et al., 2005) have shown that, in human T cells, PGE2 induces IL-8 synthesis through 
an NF-B-independent pathway via its EP1- and EP4-type receptors (PGE2EP1 and 
PGE2EP4, respectively). We have demonstrated that PGE2 at physiological, as well as 
pathological, concentrations induced IL-8 production thorough the increased expression of 
PGE2EP4 receptors in synovial fibroblasts of RA in vitro (Shibata et al., 2009b). The present 
results were of particular interest, since the effect of PGE2 on IL-8 production was found in 
the IL-1-pretreated MH7A cells. We demonstrated that the newly expressed-PGE2 
receptors are involved in this process.  
These findings show the complexity with which PGE2 regulates IL-8 synthesis by 
inhibiting or enhancing its production depending on the cell types and environmental 
conditions. Therefore, we proposed that, in IL-1-stimulated synovial fibroblasts in RA 
patients, PGE2 induces IL-8 mRNA transcription by the activation of different signal 
transduction pathways from the conventional IL-1-stimulated pathways, including PGE2 
receptor EP4-triggered pathways. IL-1 enhanced the gene expression of IL8 and PTGER4 
(Shibata et al., 2009b), subsequently IL-8 production was enhanced by IL-1 and PGE2 
from environmental neutrophils/macrophages in the synovial tissues. These results may 
therefore highlight a new important role for PGE2 in regulating IL-8 production by the 
synovial fibroblasts of RA patients, confirming the pro-inflammatory activity of this 
prostaglandin. 
2.3 Apoptotic signaling 
Inflammation of the synovial membrane results in the development of aggressive 
granulation tissue, called “pannus”. Pannus tissue is composed mainly of inflammatory 
cells such as macrophages and FLSs. By a microarray analysis, the 
apoptosis/proliferation-related molecules included those involved in processes associated 
with negative/positive regulation of cell proliferation, apoptosis/anti-apoptosis, cell 
death, cell proliferation and regulation of the cell cycle, and a large number of these genes 
were influenced by IL-1 (Fig. 1). Interestingly, whereas the expression of the gene 
encoding the apoptosis inhibitor cIAP (BIRC3) was enhanced (4.8-fold), the expression of 
those encoding the cell death inducing molecule FOSL2 (FOS-like antigen 2, 0.4-fold)) and 
the cell proliferation-related molecule EDNRA (endothelin receptor type A, 0.2-fold) were 
both suppressed. We attempted to apply the IL-1-inducible genes to a typical pathway 
atlas involving apoptotic signaling (Fig. 4A). The expression of BIRC3, which encodes the 
anti-apoptotic protein cIAP, implies that IL-1 signaling leads to inhibition of apoptotic 
signaling, as expression of cIAP should exert an inhibitory effect on caspase 3 activity 
(Rothe et al., 1995, Budihardjo et al., 1999). To confirm the increased cIAP production in 
MH7A cells, we found that levels of the BIRC3 transcript were substantially increased in 
the IL-1-induced MH7A cells (Fig. 4B).  
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A. The gray symbols indicate the IL-1-inducible genes (>2.0-fold) in the apoptosis signaling pathway. 
B. The time-dependent effects of IL-1 on the gene expression of cIAP (BIRC3), which negatively 
regulates apoptotic signaling, were examined using MH7A cells.  
Fig. 4. An atlas of an apoptosis signaling pathway  
It has been suggested that RA is driven by a network of closely connected interdependent 
pathogenic mechanisms involving innate and adaptive immunity that ultimately lead to 
synovial inflammation and aggressive synovial overproliferation during the terminal 
destructive phase (Firestein, 2003). Furthermore, in a chronically inflamed 
microenvironment, these destructive changes are driven by invasive synovial hyperplasia 
and neovascularization (pannus formation) at the interface between the synovium and intra-
articular space. During the process of synovial pannus formation, FLSs actively contribute to 
the inflamed and destructive local microenvironment by secreting a variety of inflammatory 
mediators, which lead to tissue degradation. In response to IL-1 and TNF-, FLSs also 
secrete angiogenic growth factors, such as vascular endothelial growth factor (VEGF) 
(Nagashima et al., 1999) and basic fibroblast growth factor (bFGF), which are essential for 
the pathophysiological neovascularization in RA joints. In addition, we have identified that 
BIRC3 is upregulated, making it a candidate mediator of FLS overproliferation in RA. BIRC3 
encodes cIAP, which is a key negative regulator of apoptotic signaling in FLSs. The resulting 
inhibition of FLS apoptosis in the inflamed area would be expected to contribute to the 
formation of the pannus in the RA joint.  
3. Protein chip analysis 
3.1 ECM degradation 
A RayBio biotin label-based human antibody array I (RayBiotech, Inc.) was used to measure 
the expression levels of 507 proteins in culture medium conditioned by MH7A cells. Table 1 
presents the results of the biotin label-based antibody array analysis of secreted proteins that 
categorized interleukins, and molecules involved in ECM metabolism. IL-12 p70 and IL-8 were 
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both abundantly expressed in the IL-1-induced MH7A cells (57.8- and 12.6-fold increases, 
respectively). IL-12 is a heterodimer expressed in RA synovial tissue (Morita et al., 1998); 
dendritic cells and macrophages produce IL-12 within minutes of activation, and it plays a 
central role in the development of Th1 responses (Hunter, 2005). The biological functions of 
these cells are not yet fully understood, but they are known to play a role in the differentiation 
and proliferation of T cells of the Th1 phenotype. Th1 responses in turn are deemed to be of 
particular importance in inflammatory arthritis, including RA. This induction of IL-12p70 by 
IL-1 in MH7A cells may be the first in vitro evidence of IL-12 expression in RA. This is 
noteworthy, because Connell & McInnes (Connell & McInnes, 2006) suggested in their review 
that IL-12 likely contributes to the pathology of inflammatory joint disease. If this is the case, it 
may represent a potentially useful therapeutic target. 
  
Fold Protein Name 
Non-treated IL-1b-treated 
Normalized Raw (n=3) Normalized Raw (n=3) 
ILs      
57.8 IL-12 p70 0.01 nd 0.58 3384 ± 104 
12.6 IL-8 0.01 nd 0.13 737 ± 104 
2.6 IL-16 0.01 49 ±  99 0.03 162 ± 54 
      
MMPs      
3.7 MMP-10 0.01 nd 0.04 219 ± 44 
2.3 MMP-11 (Stromelysin-3) 0.01 nd 0.02 134 ± 26 
      
TIMPs      
0.3 TIMP-1 0.72 3270 ± 1051 0.24 1395 ± 129 
0.4 TIMP-3 0.28 1296 ± 65 0.11 643 ± 296 
RayBio biotin label-based human antibody array I (RayBiotech, Inc.) was used to measure the 
expression levels of 507 proteins in culture medium conditioned by MH7A cells. The cell were cultured 
for 16 h and then treated with IL-1 (0.1 U/ml) for 3 h. The cultured medium from five wells was then 
combined and dialyzed against PBS (pH 8.0), and an internal control protein was added to the 400 µl of 
dialyzed sample medium. The procedure used for biotin labeling, blocking and incubation of the 
antibody array, as well as fluorescence detection were carried out according to the operating manual 
from RayBiotech. The images were captured using an Axon GenePix laser scanner. Biotinylation of the 
internal control protein yielded a positive control signals that was used to identify the orientation of the 
results and help normalize them for comparison of those from the untreated and IL-1-treated MH7A 
cell arrays. Values below 0.01 were set to 0.001. 
Table 1. IL-1-induced protein. 
On the other hand, the levels of two MMP family enzymes, MMP-10, and MMP-11 were 
upregulated by IL-1, while the levels of TIMP-1 and -3 were downregulated. As the overall 
MMP activity reflects a balance between the amount of MMPs and TIMPs present, the 
reduction in TIMP-1 and TIMP-3 levels seen in MH7A cells would be expected to shift the 
balance in favor of increased MMP activity. Taken together, these data suggest that IL-1 
elicits a series of responses in the synovial fluid, leading to the pathology seen in RA, 
including enhanced expression of inflammatory cytokines and enzymes, and a reduction in 
the ability to protect against the destruction of the tissue ECM. 
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4. Medical treatments for RA 
Several disease-modifying anti-rheumatic drugs (DMARDs) have been used to control the 
progression of RA. While the majority of these drugs act as immunomodulatory agents, 
some also act by inhibiting cytokines and endothelial cell proliferation (Cozzolino et al., 
1993, Volin et al., 1999). Newly developed biological response modifiers (biologics) offer 
even more hope, having a greater potential to suppress disease activity, and improve the 
quality of life of RA patients. 
4.1 Disease-modifying anti-rheumatic drugs, TNF- blockers, and other agents 
Guidelines advocate treatment with DMARDs as soon as RA is diagnosed to control 
symptoms and delay disease progression (Smolen & Steiner, 2003, O'Dell, 2004, Saag et al., 
2008). DMARDs slow the progression of the joint damage that leads to loss of function, 
whereas drugs such as nonsteroidal antiinflammatory drugs and corticosteroids only 
control the symptoms (Kirwan & Power, 2007). On the other hand, targeted inhibition of 
TNF- is an effective therapy widely used against RA and other rheumatic diseases. The 
advent of TNF blockers has led to substantial improvement in the management of active RA 
refractory to conventional DMARDs. While on a patient-population level, the efficacy of the 
TNF blockers infliximab, etanercept, and adalimumab seems comparable, on an individual 
level, there are no clear-cut methods for assessing whether there will be a response to anti-
TNF therapy, let alone which agent would yield the best outcome. The updated consensus 
statement on biological agents for the treatment of rheumatic diseases states that the optimal 
treatment for anti-TNF refractory RA remains to be determined. However, most 
importantly, it is not yet possible to identify prior to therapy which patients will fail to 
respond or who are at increased risk for adverse drug reactions (Mendonça et al., 2011). 
Given the important role that TNF-α antagonists play in managing rheumatoid arthritis and 
the concern for safety during long-term therapy, such factors need to be determined as soon 
as possible.   
Glucocorticoids have potent immunosuppressive effects and have been widely used in the 
management of chronic inflammatory diseases such as severe RA. A number of studies have 
focused on the cellular and molecular mechanisms underlying the anti-inflammatory effects 
of glucocorticoids such as dexamethasone (Dex). Glucocorticoids exert their effects via 
intracellular receptors that act as potent transcriptional activators of genes that possess 
glucocorticoid responsive elements. By regulating gene expression, glucocorticoids suppress 
the production of pro-inflammatory proteins, such as cytokines, chemokines and some 
enzymatic mediators. However, the therapeutic management of long-term pathological 
conditions with steroids is often linked to unwanted side effects involving the 
cardiovascular system (Suissa et al., 2006). 
4.2 Proposal of RA therapy using linear polarized infrared light   
It is unclear whether early treatment with biologics should continue to be recommended, 
given their potential to slow disease progression and extend productivity on the one hand, 
while causing unwanted side effects and risks due to drug-associated health care utilization 
on the other. Therefore, we examined the potential of photodynamic therapy using a linear 
polarized infrared light (LPIL). Laser therapy is a new arthroscopic technique to treat 
inflammation of the synovial membrane. Following gallium-aluminum-arsenide (Ga-Al-As) 
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laser treatment, histological examination of the irradiated synovial membranes showed 
flattening of the epithelial cells, decreased villous proliferation, narrower vascular lumens 
and less infiltration by inflammatory cells than was seen in non-irradiated synovia. An 
alternative approach makes use of a linear polarized infrared light (LPIL) instrument (Super 
Lizer™, Tokyo Iken Co., Ltd), which has been used clinically with good effects in several 
patients with inflammatory disease. LPIL can be applied during physical therapy to relieve 
pain, and several studies have shown that such irradiation also relieves temporomandibular 
joint pain (Yokoyama & Oku, 1999), improves the structure of stored human erythrocytes 
(Yokoyama & Sugiyama, 2003), and improves the flexibility of shoulder and ankle joints 
(Demura et al., 2002). A fuller understanding of the anti-inflammatory mechanism of LPIL 
in rheumatoid synoviocytes could serve as the basis for improved treatment of RA patients 
in the future. 
We treated MH7A cells IL-1 (0.1 U/ml) and/or Dex (1 µM) or LPIL (3.8 J/cm2). Microarray 
experiments were then carried out using the Affymetrix Focus Array HG-8500 GeneChip. 
As shown in Fig. 5A, the transcription of numerous genes was up- or down-regulated to a 
greater degree in cells treated with Dex than in those treated with LPIL. Likewise, the effects 
of LPIL irradiation on the transcription levels of many genes were smaller than those of IL-
1. In total, 120 (IL-1), 561 (Dex), 877 (Dex/IL-1), 88 (LPIL) and 90 (LPIL/IL-1) genes 
were up- or downregulated by the different treatments (Fig. 5B).  
 
 
The global gene expression in MH7A cells. The normalized gene expression is shown. MH7A cells were 
treated with Dex or LPIL in the presence or absence of IL-1 before the extraction of their RNA. N, 
untreated cells; IL, IL-1-treated cells; D, Dex-treated cells. B. The numbers of up- and down-regulated 
genes. Genes whose expression was increased or decreased by over two-fold are indicated. [This figure 
is modified from (Shibata et al., 2009b)] 
Fig. 5. Microarray data analysis.  
We focused on the genes that were up-regulated by at least 2.0-fold in cells treated with 
IL-1 and then suppressed by the anti-inflammatory treatments. IL-8 transcripts showed 
the largest increase (20.8 fold), and LPIL and Dex each suppressed this gene expression. 
Others genes, including CXCL1, 2, 3, IL6, and IL1B, which respectively encode Gro-, 
Gro-, Gro-, IL-6 and IL-1, were also suppressed by LPIL to the same extent as by Dex 
(Table 2). Thus, although for the most part LPIL irradiation did not alter the transcription 
levels to the same degree as Dex did, IL-1 inducible genes, such as the CXCL type 
chemokines, IL6 and IL1B, were clearly suppressed by LPIL irradiation. To evaluate the  
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Gene Title Affy 
IL-1/None IL-1+Dex 
/None 
IL-1+LPIL 
/None 
Fold 
Normalized 
intensity 
Raw 
Data 
Fold Fold 
IL8 interleukin 8, CXCL8 20.2 0.86/0.04 (P/A) 5.6 7.6 
CXCL1 
chemokine (C-X-C motif) ligand 1, 
GRO1 
4.1 3.36/0.82 (P/P) 3.2 1.8 
CXCL2 
chemokine (C-X-C motif) ligand 2, 
GRO2 
4.0 3.78/0.94 (P/P) 2.4 3.1 
CXCL3 
chemokine (C-X-C motif) ligand 3, 
GRO3 
2.7 0.85/0.32 (M/A) 3.2 2.1 
IL6 Interleukin 6 2.7 5.51/2.07 (P/P) 1.0 2.2 
IL1B Interleukin 1, beta 2.5 2.33/0.92 (P/M) 1.4 1.5 
Table 2. Inhibitory effects of anti-inflammatory treatments on IL-1-induced gene expression 
inhibitory effects of LPIL irradiation on IL-1 inducible inflammation, we next used an 
ELISA to monitor IL-1 induced IL-8 synthesis and secretion from MH7A cells. We found 
that IL-1 strongly induced IL-8 production, and that the effect was similarly suppressed by 
Dex or LPIL (Fig. 6). We compared the effects of one-time LPIL irradiation and Dex 
administration on the production of IL-8. Even one period of exposure to LPIL irradiation 
diminished the IL-1-induced production of IL-8 to the same extent as administration of 1 
µM Dex to the cells. Furthermore, using end-point PCR and real-time PCR, we determined 
that there were corresponding decreases in the expression of IL-8 mRNA (Fig. 6). It is also 
noteworthy that the inhibitory effects on IL-8 transcription increased with increasing optical 
pulse energy.  
The genes whose products are involved in NF-B signaling (e.g., NFKB1, RelA, and 
C/EBP-) were not induced by IL-1 stimulation as determined by the microarray 
analysis. On the other hand, increasing evidence has highlighted the importance of NF-B 
modification in the regulation of its transcriptional activity. For instance, it appears that 
NF-B activity can be modulated by phosphorylation of the RelA subunit. Recent 
evidence indicates that the phosphorylation of the RelA subunit on S276 and S536 is 
physiologically induced by various proinflammatory stimuli. Zhong et al. (2002) found 
that LPS stimulates protein kinase A-dependent phosphorylation of RelA on S276 and 
subsequently recruits the transcription coactivator CREB binding protein (CBP)/p300 to 
stimulate NF-B-mediated transcription. Furthermore, it appears that S536 of endogenous 
cytoplasmic RelA is phosphorylated in response to a wide variety of NF-B stimuli and is 
then rapidly dephosphorylated in the nucleus (Sakurai et al., 1999, Sakurai, 2003, Yang et 
al., 2003, Mattioli et al., 2004).  
Because transduction of the IL-1 signal is tightly regulated in MH7A cells via a network 
involving NF-B, we tried to measure the levels of NF-B phosphorylation. As shown in Fig. 
7, the total levels of NF-B-bound RelA were nearly the same in all of the treated MH7A 
cells (right panel). Phosphorylation of the RelA subunit on both S276 and S536 was 
significantly increased by IL-1 stimulation, and was decreased in the presence of Bay11-
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7085 (left and center panels). Interestingly, LPIL irradiation suppressed the phosphorylation 
of both S276 to the same degree as Dex in IL-1-stimulated MH7A cells.  
The extent to which the risk of side-effects may be driven by drugs that decrease immune 
surveillance (notably, DMARDs including TNF- blockers, and glucocorticoid agents), is not 
completely clear. This issue has gained interest in light of reports of serious infections in 
patients receiving newer RA therapies.  
 
 
The inhibitory effects of LPIL or Dex on the production of IL-8 in MH7A cells. An end-point PCR analysis 
shows that LPIL irradiation inhibits IL8, but not GAPDH, gene expression. The power level of the 
irradiation was changed by adjusting the power dial on the Super Lizer™ to 30%, 50%, or 80%. The 
duration of the irradiation was the same for all wells. A real-time PCR analysis shows the dose-dependent 
inhibitory effects of LPIL on IL-8 gene expression. [This figure is modified from (Shibata et al., 2009a)] 
Fig. 6. The transcriptional regulation of IL-8 by LPIL and Dex in IL-1-stimulated MH7A 
cells. 
5. Conclusion 
To study the pathophysiological mechanisms involved in chronic inflammatory disorders 
such as RA, in vitro culture systems using IL-1-activated FLSs from RA patients have 
become useful models of the first step in RA-induced joint deterioration. Our findings 
demonstrate the utility of profiling the gene expression in IL-1 stimulated-MH7A cells, 
with the supposition that it is representative of the early disease stage of RA. By employing 
GeneChips and IPA, we were able to show that autocrine induction of IL-1 gene expression 
may underlie the strong expression of several inflammatory cytokines, including IL-8, IL-1 
and IL-6, and suggest that continuous IL-1 production has an exacerbating effect on RA. In 
addition, we have identified upregulation of the BIRC3 gene as a candidate mediator of the 
FLS overproliferation in RA. BIRC3 encodes cIAP, which is a key negative regulator of 
apoptotic signaling in FLSs. The resulting inhibition of FLS apoptosis in the inflamed area 
would be expected to contribute to the formation of the pannus in the RA joint. It is our 
expectation that further studies of the comprehensive information provided by the 
GeneChip/IPA analysis and antibody array systems will provide a means to ease the 
suffering caused by RA.  
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MH7A cells were cultured for 16 h in 96 well plates and then used to assess the phosphorylation of the NF-
kB RelA subunit. Cells were irradiated with LPIL for 680 s immediately after stimulation with IL-1b for 2 h, 
or Dex was added to cells at the same time as IL-1b. Some cells were pretreated with Bay11-7085 for 1 h 
before addition of the IL-1b. After stimulation with IL-1b, the culture medium was removed, the cells were 
fixed by microwaving, and the levels of phosphorylation of the NF-kB RelA subunit on S276 and S536 
were measured using a Cellular Activating of Signaling ELISA CASE™ kit. The results are expressed as 
the means ± SD (n=6); *P < 0.005 vs. untreated. [This figure is modified from (Shibata et al., 2009a)] 
Fig. 7. The  effects of Bay11-7085, LPIL or Dex on the phosphorylation of S536 and S276 of 
the NF-kB RelA subunit  
IL-8, originally called monocyte-derived neutrophil chemotactic factor, is a potent 
chemokine, causing recruitment and infiltration of neutrophils and T cells into local 
inflammatory sites. The infiltration of neutrophils contributes to inflammation and has been 
implicated in various diseases. The transcription factors NF-B, AP-1, and NF-IL-6 are all 
involved in the stimulus-induced expression of IL-8. Subsequent IPA revealed that NF-B 
signaling was likely important for the synthesis and release of the IL-8 protein. We then 
found that IL-1-induced IL-8 release from MH7A cells requires the activation of the 
canonical NF-B pathway and kinases catalyzing its phosphorylation. Furthermore, 
treatments with Dex or LPIL suppressed the phosphorylation of S276 of the RelA subunit, 
which would in turn inhibit the translocation of NF-B into the nucleus, where it could 
interact with the promoter region of the IL8 gene. 
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